Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 3, 2010, Pages 217-222

  Su, Changhai ^a   Ji, Hui ^a   Su, Yixin ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Ordos Center Hospital   (China)

Author keywords

Adverse drug reactions; Hospital pharmacists; Knowledge; Opinions

Indexed keywords

ADVERSE DRUG REACTION; ARTICLE; CHINA; CONTINUING EDUCATION; DEMOGRAPHY; DRUG SURVEILLANCE PROGRAM; GENERAL HOSPITAL; HEALTH SURVEY; PATIENT CARE; PHARMACIST; PHARMACIST ATTITUDE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PROFESSIONAL PRACTICE; STRUCTURED QUESTIONNAIRE; TERTIARY HEALTH CARE;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; ATTITUDE OF HEALTH PERSONNEL; CHINA; EDUCATION, PHARMACY, CONTINUING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOSPITALS, GENERAL; HUMANS; MALE; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; QUESTIONNAIRES; TIME FACTORS;

EID: 77649213514     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1792     Document Type: Article

References (37)

1. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004; 329: 15-19.
2. Arulmani R, Rajendran SD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol 2008; 65: 210-216.
3. Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther 2006; 31: 335-341.
4. Dormann H, Muth-Selbach U, Krebs S, et al. Incidence and costs of adverse drug reactions during hospitalization: computerized monitoring versus stimulated spontaneous reporting. Drug Saf 2000; 22: 161-169.
5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
6. Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29: 385-396.
7. Du W, Guo JJ, Jing Y, Li X, Kelton CM. Drug safety surveillance in China and other countries: a review and comparison. Value Health 2008; 11: S130-136.
8. State Food & Drug Administration of China (SFDA). SFDA Press Release. http://www.china.com.cn/zhibo/2008-07/08/content-15965492. htm [Accessed 18 March 2009].
9. Ekman E, Bäckström M. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol 2009; 65: 43-46.
10. Aagaard L, Stenver DI, Hansen EH. Structures and processes in spontaneous ADR reporting systems: a comparative study of Australia and Denmark. Pharm World Sci 2008; 30: 563-570.
11. Grootheest Kvan, Olsson S, Couper M, de Jong-van den Berg L. Pharmacists' role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf 2004; 13: 457-464.
12. Grootheest ACvan, Puijenbroek EPvan, de Jong-van den Berg LTW. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11: 205-210.
13. Ahmad SR, Freiman JP, Graham DJ, Nelson RC. Quality of adverse drug experience reports submitted by pharmacists and physicians to the FDA. Pharmacoepidemiol Drug Saf 1996; 5: 1-7.
14. Wang HC, Chen LY, Lau AH. Pharmacy practice and education in the People's Republic of China. Ann Pharmacother 1993; 27: 1278-1282.
15. Jing Y, Kelton CM, Li X, Guo JJ. Lethal drug probe in China: the case of Xinfu clindamycin. Pharmacoepidemiol Drug Saf 2007; 16: 928-932.
16. Wang Y, Tang Z. The analysis of ADRs related to houttuynia herb injections. Chin J New Drugs 2006; 15: 739-741.
17. Temporary regulation for pharmacy administration in medical organizations. WeiYiFa (Ministry of Health Medical Official Document), 2002; 24.
18. Ministry of Health P. R. China. The Measures for the Administration of Prescriptions. http://www.gov.cn/ziliao/flfg/2007-03/13/content-549406. htm [Accessed 18 April 2009].
19. Hillier S, Shen J. Health care systems in transition: People's Republic of China. Part I: an overview of China's health care system. J Public Health Med 1996; 18: 258-265.
20. Blumenthal D, Hsiao W. Privatization and its discontents - the evolving Chinese health care system. N Engl J Med 2005; 353: 1165-1170.
21. Hasford J, Goettler M, Munter KH, Muller-Oerlinghausen B. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 2002; 55: 945-950.
22. Eland IA, Belton KJ, van Grootheest AC, et al. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 1999; 48: 623-627.
23. Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol 2001; 51: 81-86.
24. Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf 2000; 23: 165-172.
25. Joop JHox, Edith DDeLeeuw. A comparison of nonresponse in mail, telephone, and face-to-face surveys. Qual Quant 1994; 28: 329-344.
26. Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci 2008; 30: 556-562.
27. Schuwirth LW, van der Vleuten CP, Donkers HH. A closer look at cueing effect in multiple choice questions. Med Educ 1996; 30: 44-49.
28. Li Q, Zhang SM, Chen HT, et al. Awareness and attitudes of healthcare professional in Wuhan, China to the reporting of adverse drug reactions. Chin Med J 2004; 116: 856-861.
29. Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong. Ann Pharmacother 1994; 28: 1400-1403.
30. Spinewine A, Dhillon S, Mallet L, et al. Implementation of ward-based clinical pharmacy services in Belgium - description of the impact on a geriatric unit. Ann Pharmacother 2006; 40: 720-728.
31. Granas AG, Buajordet M, Stenberg-Nilsen H, Harg P, Horn AM. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf 2007; 16: 429-434.
32. Irujo M, Beitia G, Bes-Rastrollo M, et al. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf 2007; 30: 1073-1082.
33. Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother 1995; 29: 365-369.
34. Melody RP, Hong S, Li Y, et al. Clinical pharmacy education in China. American Journal of Pharmaceutical Education 2008; 72: 1-7.
35. Grootheest ACvan, Mes K, de Jong-van den Berg LTW. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract 2002; 10: 267-272.
36. Moore N. The role of the clinical pharmacologist in the management of adverse drug reactions. Drug Safety 2001; 24: 1-7.
37. Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf 2007; 16: 223-228.